India's only fully vertically-integrated cardiovascular device manufacturer — the single facility in the country combining in-house development and manufacturing of stents, stent delivery systems, PTCA balloon catheters, guiding catheters and angiographic diagnostic catheters. 1,60,000 sq.ft Hyderabad facility with 35,000 sq.ft of Class 10K cleanrooms; ISO 13485:2016 certified and DSIR-recognized. Early development was mentored by former President Dr. APJ Abdul Kalam. Acquired Multimedics to add CE-marked stent systems and expanded into transcatheter heart valves (TricValve, Vienna Aortic Valve SE) for structural heart disease — also active as an OEM partner for other device companies.
India's first indigenously developed drug-eluting coronary stent — L605 cobalt-chromium platform with open/closed cell strut-locking design and biodegradable PLA polymer coating.
Sirolimus (Premier+) and Everolimus (Pristine+) eluting coronary stent systems on a cobalt-chromium platform with enhanced deliverability and low entry profile.
Transcatheter bicaval valve system for tricuspid regurgitation and right heart failure — implanted at Apollo, Fortis and other major Indian cardiac centres.
Self-expanding transcatheter aortic valve for structural heart interventions.
PTCA balloon catheters, guiding catheters and femoral/radial angiographic diagnostic catheters manufactured in-house.